Clinical Trial Update: Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating gemcitabine in combination with cisplatin as neoadjuvant chemotherapy for non-small cell lung cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Platinol (cisplatin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED